BPC-157 20mg — Vial Spec, Reconstitution Math & COA

Overview of the 20mg BPC-157 Vial Specification

The 20mg specification of Body Protection Compound-157 (BPC-157) is engineered for research facilities conducting large-scale assays, multi-week animal study runs, or parallel cell culture experiments where high total peptide mass is required. Each vial contains 20 milligrams of highly purified, lyophilized BPC-157 acetate salt alongside a stabilizing matrix to preserve peptide integrity during shipment and storage.

Primary investigators and analytical technicians select the 20mg vial format to minimize intra-assay variance caused by batch-to-batch reconstitution differences. By preparing a single bulk stock solution from a 20mg vial, laboratories ensure uniform concentration across all experimental replicates. Researchers looking to explore our full line of synthetic compounds can view the complete inventory on our all peptides catalog.

PX1 Research Catalog Availability & Ordering Context

PX1 Research maintains rigorous inventory standards for research-grade peptides manufactured in domestic, ISO 17025-accredited, GMP-compliant facilities. While standard inventory frequently centers on 5mg and 10mg unit sizes for routine experimental work, high-yield formats like the 20mg vial are supplied for institutional projects and bulk research requirements.

If the 20mg vial configuration is temporarily out of stock or designated as a custom production run, investigators can access equivalent overall mass by utilizing our standardized BPC-157 product page to select standard 5mg or 10mg vials. High-volume laboratories requiring dedicated single-vial 20mg fills or custom aliquot parameters are encouraged to consult our wholesale lab account portal for specialized order scheduling.

Reconstitution Mathematics for 20mg Lyophilized Stock

Accurate concentration calculations are vital when reconstituting a 20mg vial to maintain reproducible dosing parameters in preclinical models. Depending on the volumetric constraints of the target assay or dosing system, researchers typically select 1.0 mL, 2.0 mL, or 3.0 mL of sterile diluent (such as Bacteriostatic Water or Sterile 0.9% Sodium Chloride).

The concentration ($C$) of the reconstituted solution is determined by dividing the total mass ($m = 20\text{ mg}$) by the diluent volume ($V$). The resulting values yield the following stock concentration benchmarks:

• 1.0 mL Diluent Volume: $20\text{ mg} / 1.0\text{ mL} = 20.0\text{ mg/mL}$ ($20,000\text{ }\mu\text{g/mL}$ or $20\text{ }\mu\text{g/}\mu\text{L}$). • 2.0 mL Diluent Volume: $20\text{ mg} / 2.0\text{ mL} = 10.0\text{ mg/mL}$ ($10,000\text{ }\mu\text{g/mL}$ or $10\text{ }\mu\text{g/}\mu\text{L}$). • 3.0 mL Diluent Volume: $20\text{ mg} / 3.0\text{ mL} = 6.67\text{ mg/mL}$ ($6,670\text{ }\mu\text{g/mL}$ or $6.67\text{ }\mu\text{g/}\mu\text{L}$).

To quickly verify custom volumes or specific target microgram concentrations without manual calculation errors, research staff can utilize our interactive reconstitution calculator.

Aliquot Planning and Solution Stability Protocols

Reconstituting a 20mg vial yields a significant volume of liquid peptide solution. Repeated freeze-thaw cycles degrade peptide bonds via physical stress and surface interaction, reducing the effective titer over time. Therefore, proper aliquot planning immediately following reconstitution is essential for maintaining experimental validity.

Upon adding the chosen diluent volume and allowing the lyophilized cake to fully dissolve via gentle swiveling (avoiding high-shear vortexing), the stock solution should be divided into sterile, low-binding microcentrifuge tubes. Aliquots sized for single-day laboratory use (e.g., 100 $\mu\text{L}$ to 250 $\mu\text{L}$) should be stored at -20°C or -80°C. Working aliquots designated for immediate use within 7 to 14 days may be held under refrigerated conditions (2°C to 8°C).

Molecular Profile and Mechanisms in Tissue Repair Models

BPC-157 is a synthetically produced 15-amino acid peptide derived from a naturally occurring protective protein sequence identified in human gastric juice. Preclinical studies suggest that BPC-157 acts primarily as a modulating signaling agent in tissue repair and cell survival cascades.

In vitro data and animal models demonstrate that BPC-157 promotes the accelerated repair of tendons, ligaments, skeletal muscle, and gut lining tissue. The underlying biological mechanism involves the upregulation of vascular endothelial growth factor (VEGF) expression, activation of the FAK-paxillin pathway to induce cellular migration to injury sites, and the mitigation of pro-inflammatory cytokine expression. Researchers interested in the underlying pathways can review comprehensive literature summaries in our peptide research hub.

Comparative Analysis: Regenerative and Repair Compounds

When designing tissue repair and cellular migration experiments, researchers often evaluate BPC-157 alongside other well-characterized biological compounds. Distinct structural classes offer complementary or contrasting mechanisms of action in tissue injury models.

For instance, while BPC-157 acts prominently on localized angiogenic pathways and focal adhesion formation, TB-500 (a synthetic segment of Thymosin Beta-4) operates via actin sequestration and cell migration enhancement. Similarly, GHK-Cu influences extracellular matrix remodeling through copper-dependent gene regulation, and KPV functions via alpha-MSH derivative anti-inflammatory signaling. Evaluating these compounds in parallel assays provides insights into synergistic pathway activation in wound healing models.

Lot-Matched COA and Quality Assurance Specifications

Every batch of BPC-157 manufactured for PX1 Research undergoes strict analytical validation before release. Each individual fill volume—whether 5mg, 10mg, or 20mg—is paired with a lot-matched Certificate of Analysis (COA) verifying purity, identity, and safety parameters.

Purity is assessed using High-Performance Liquid Chromatography (HPLC), requiring a minimum threshold of ≥98.0% peptide purity. Mass identity is confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS) to ensure the exact molecular weight matches the theoretical value ($1419.5\text{ Da}$). Furthermore, bacterial endotoxin testing via Chromogenic LAL assay guarantees endotoxin levels remain below $<0.01\text{ EU/mg}$, preventing confounding inflammatory responses in sensitive cell cultures or animal models. Review sample COAs and testing parameters on our certificate of analysis directory.

Selecting the Optimal Vial Size: 5mg, 10mg vs. 20mg

Determining whether a 5mg, 10mg, or 20mg vial format is appropriate depends entirely on the design and timeline of the research protocol. Selecting the incorrect vial mass can lead to unnecessary peptide waste or increased experimental variability.

Smaller vial sizes (5mg or 10mg) are ideal for short-duration studies, initial exploratory assays, or protocols requiring highly concentrated single-use doses where storage of reconstituted solution is undesirable. Conversely, the 20mg format is most efficient for ongoing daily animal dosing models, multi-well cell culture screening, or high-throughput automated workstations. Institutional researchers analyzing high-volume requirements can consult our guides on pentadecapeptide mechanisms to align vial mass with experimental design.

Laboratory Storage Directives and Handling Guidelines

To maximize shelf life and maintain biological activity, lyophilized BPC-157 20mg vials must be stored under controlled environmental conditions upon receipt. Unopened lyophilized vials remain stable at room temperature for brief transport windows but should be transferred to -20°C for medium-term storage (up to 12 months) or -80°C for long-term preservation.

Exposure to direct ultraviolet light, ambient heat, and moisture must be strictly avoided. Reconstitution should occur in a clean room environment or laminar flow hood using sterile technique. Avoid violent agitation during dissolution to prevent mechanical denaturation of the peptide chain.